loader
Please Wait
Applying Filters...

Athena Athena

X

Information, Expiry & Status of FDA Orange Book Patents covering Bupropion

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NALPROPION (20)

02 TWI PHARMS (1)

filter

01 7375111 (1)

02 7462626 (1)

03 7674479 (1)

04 8088786 (1)

05 8318788 (1)

06 8722085 (1)

07 8815889 (1)

08 8916195 (1)

09 9107837 (1)

10 9125868 (1)

11 9248123 (1)

12 9633575 (1)

13 10231964 (1)

14 10307376 (1)

15 10403170 (1)

16 10828294 (1)

17 10835527 (1)

18 11033543 (1)

19 11139056 (1)

20 11278544 (1)

21 11324741 (1)

filter

01 Blank (21)

filter

01 Y (3)

02 Blank (18)

filter

01 2024-04-21 (1)

02 2024-07-20 (2)

03 2025-03-26 (1)

04 2027-06-04 (1)

05 2027-06-25 (1)

06 2027-11-08 (4)

07 2029-02-03 (1)

08 2029-05-29 (1)

09 2030-02-02 (1)

10 2031-01-10 (1)

11 2032-01-13 (1)

12 2033-06-05 (2)

13 2033-06-25 (1)

14 2034-07-02 (3)

URL Supplier Web Content
8722085
2027-11-08
U-1585
200063
USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8815889
2024-07-20
U-1586
200063
FOR EFFECT ON BLOOD GLUCOSE PARAMETERS IN PATIENTS WITH INSULIN RESISTANCE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9107837
2027-06-04
U-1639
200063
USE OF NALTREXONE AND BUPROPION IN EXTENDED-RELEASE FORM FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9125868
2027-11-08
U-1585
200063
USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
10231964
2034-07-02
U-1583
200063
FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7462626
2024-07-20
U-1583
200063
FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
10307376
2027-11-08
U-1585
200063
USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
11139056
2033-06-05
U-1583
200063
FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
10403170
2033-06-05
U-1583
200063
FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9633575
2033-06-25
U-1583
200063
FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY